ARYx Therapeutics Inc (ARYX.PK)

ARYX.PK on OTC Markets Group

0.01USD
22 Jul 2014
Price Change (% chg)

$-0.00 (-10.00%)
Prev Close
$0.01
Open
$0.01
Day's High
$0.01
Day's Low
$0.01
Volume
200
Avg. Vol
18,590
52-wk High
$0.05
52-wk Low
$0.00

ARYX.PK

Chart for ARYX.PK

About

ARYx Therapeutics, Inc. is a United States-based pharmaceutical Company. The Company is developing a proprietary portfolio of patient-targeted, first-in-class monoclonal antibodies designed to treat seriously ill patients with difficult-to-treat diseases. It is engaged in retrometabolic drug design that focuses on the safety of... (more)
No analyst recommendations are available for ARYX.PK.

Overall

Beta: 0.03
Market Cap (Mil.): $0.30
Shares Outstanding (Mil.): 33.46
Dividend: --
Yield (%): --

Financials

  ARYX.PK Industry Sector
P/E (TTM): -- 35.64 36.09
EPS (TTM): -0.61 -- --
ROI: -487.55 18.92 18.19
ROE: -- 19.68 19.06
Search Stocks

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $102.11 0.00
Pfizer Inc. (PFE.N) $30.10 -0.09
Novartis AG (NOVN.VX) CHF79.25 -0.15
Sanofi SA (SASY.PA) €76.63 +0.30
AstraZeneca plc (AZN.L) 4,366.00p +5.00
Bayer AG (BAYGn.DE) €99.38 +0.09
Bayer AG (BAYE.F) -- --
3M Co (MMM.N) $145.53 +0.41
Bristol-Myers Squibb Co (BMY.N) $49.80 +0.41
Bristol-Myers Squibb Co (BMYMP.PK) $829.72 -58.28

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$104.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks